Technology Novel Delivery Platform For Controlled Release Of Bacterial Metabolites To Modulate The Immune System Conditioning of the immune system by the microbiome has received substantial attention for the scientific community in recent years. Microbial metabolites are being assessed as novel therapeutic tools for various…
Technology Bioadhesive Polymer for Connecting Semiconductors to Wet Tissue This method imparts bioadhesive properties onto polymeric semiconductors, which enables effective transductions of bio-signals from biological tissues to electronic devices. The Unmet Need: Conformable and stable integration of semiconductor-based biosensing…
Technology A Gene-Modified T Cell Platform For Spatially Controlled Therapeutic Protein Delivery In Response To Radiation Engineered T cells to release cancer-killing proteins only when activated by targeted radiation, enabling precise, localized tumor treatment while minimizing side effects and improving the effectiveness of CAR-T therapy for…
Technology Antibody-Based Cell Expansion Technology For Large-Scale And Safe Amplification Of Gamma Delta T Cells Novel antibodies to rapidly and safely expand γδ T cells enabling large-scale production for cancer immunotherapies like γδ CAR-T cells, and potentially boosting these cells directly in patients The…
News Polsky 10: UtilityInnovation Group acquired for projected $2.6B | Aura Life Science joins ISS accelerator | OrisDX launches first diagnostic product The Polsky 10 is a bi-weekly newsletter featuring 10 things to know from the University of Chicago’s Polsky Center.
Program Past VCIC Participants 2026 Monarch Fund won the regional Venture Capital Investment Competition. Team members included Angela Huang, Kim Berg, Nick Thomas, Patrick Mispireta, Leah Sidell, and Joe Wang. 2025 First Pick Ventures…
